Cargando…
GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors
A fundamental challenge in treating disease is identifying molecular states that affect cellular responses to drugs. Here, we focus on GSK-3, a key regulator for many of the hallmark behaviors of cancer cells. We alter GSK-3 activity in colon epithelial cells to test its role in modulating drug resp...
Autores principales: | Thorne, Curtis A., Wichaidit, Chonlarat, Coster, Adam D., Posner, Bruce A., Wu, Lani F., Altschuler, Steven J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270937/ https://www.ncbi.nlm.nih.gov/pubmed/25402767 http://dx.doi.org/10.1038/nchembio.1690 |
Ejemplares similares
-
Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities
por: Singh, Dinesh Kumar, et al.
Publicado: (2010) -
Examining Crosstalk among Transforming Growth Factor β, Bone Morphogenetic Protein, and Wnt Pathways
por: Coster, Adam D., et al.
Publicado: (2017) -
Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines
por: Kang, Jungseog, et al.
Publicado: (2015) -
GSK983: A novel compound with broad-spectrum antiviral activity
por: Harvey, Robert, et al.
Publicado: (2009) -
Control of Podocyte and Glomerular Capillary Wall Structure and Elasticity by WNK1 Kinase
por: Liu, Zhenan, et al.
Publicado: (2021)